←
Cybrexa Therapeutics Inc385 posts
Cybrexa Therapeutics Inc avatar

Cybrexa Therapeutics Inc

@Cybrexa

Changing the paradigm for cancer treatment through the development of antigen-independent peptide drug conjugates. CGs:bit.ly/3GI6AU0

◷ Joined January 2019▧ 201 Photos and videos
Cybrexa Therapeutics Inc avatar
Cybrexa Therapeutics Inc@Cybrexa·11 Mar 2025

Meet Cybrexa’s leadership team built on deep experience in oncology drug development, clinical trials, and company growth. Together, we are developing the next generation of cancer therapeutics and advancing the future of cancer treatment. bit.ly/4hbRVUm

Post attachment
Cybrexa Therapeutics Inc avatar
Cybrexa Therapeutics Inc@Cybrexa·7 Mar 2025

Cybrexa’s alphalex™- enabled peptide-drug conjugates bypass traditional therapy limits by targeting universal tumor biology. Our antigen-agnostic approach means more patients with cancer may benefit from treatment, regardless of specific tumor markers. bit.ly/3CobYzO

Post attachment
Cybrexa Therapeutics Inc avatar
Cybrexa Therapeutics Inc@Cybrexa·4 Mar 2025

Cybrexa Therapeutics presented new preclinical data at #ESMOTAT25 showing alphalex™ peptide-drug conjugates achieved robust efficacy across multiple tumor models, both as monotherapy and in combination with standard treatments. Read the full results here: bit.ly/3FgoSkf

Post attachment
Cybrexa Therapeutics Inc avatar
Cybrexa Therapeutics Inc@Cybrexa·27 Feb 2025

Cybrexa will present new preclinical findings at #ESMOTAT25 on the potential of alphalex™ peptide-drug conjugates to achieve tumor-selective delivery while minimizing off-target effects. 📅 March 3 | ⏰ 5:15-6:15 PM CET | 🎤 Vishwas Paralkar, Ph.D. bit.ly/41uXCHv

Post attachment
Cybrexa Therapeutics Inc avatar
Cybrexa Therapeutics Inc@Cybrexa·12 Feb 2025

In a robust Phase 1 trial, our lead clinical-stage program, CBX-12, showed compelling safety & efficacy across six tumor types. With activity confirmed, even in heavily pretreated patients, we are advancing CBX-12 into Phase 2 trials. bit.ly/4ggu58J #biotech

Post attachment
Cybrexa Therapeutics Inc avatar
Cybrexa Therapeutics Inc@Cybrexa·18 Jun 2024

#DYK: #Cybrexa & most of our team are HQ’d in #CT, but some of us live in FL, GA, MA, NH, NJ, RI & TX. Despite the distance, Cybrexa’s commitment to raising awareness for various cancers unites our team. Last month, we wore teal ribbons on #WorldOvarianCancerDay. Check us out 👇!

0:10